Predict your next investment

HEALTHCARE | Medical Facilities & Services / Medical Laboratories & Research
phoenixpcs.com

See what CB Insights has to offer

Stage

Acquired | Acquired

About Phoenix Pharma Central Services

Phoenix Pharma Central Services (Phoenix PCS), a premier central laboratory services provider for Asia Pacific clinical trials, with laboratory facilities in Singapore and Shanghai, China. Established in 2001, Phoenix PCS is a highly respected central laboratory in Asia offering services for Phase I to Phase IV clinical trials, and has been accredited by the College of American Pathologists (CAP) since 2003. The company has an experienced staff with extensive knowledge of clinical trial operations, Asian cultures and regulatory requirements, and is well positioned to provide support to pharmaceutical and biotechnological industries in the development of drugs and medical devices.

Phoenix Pharma Central Services Headquarter Location

11 Changi North Street 1, #04-05/08 Changi North Industrial Estate

498823,

Singapore

65-6542-4784

Latest Phoenix Pharma Central Services News

ACM Global Central Laboratory Expands Global Footprint with Acquisition in Asia Pacific

Jan 23, 2014

Global Central Lab Acquires Highly Regarded Phoenix Pharma Central Services; Bolsters Asia Pacific Presence with Optimized Laboratory Facilities in Singapore and Shanghai ACM Global Central Laboratory ACM Global a diagnosti...

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.